NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 22 February 2010 A Cochrane review suggests that aripiprazole may be slightly less efficacious than olanzapine and similar to risperidone▼ in the treatment of schizophrenia. However, the clinical significance […]
Category Archives: CNS and mental health
NPC Archive Item: Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 25 January 2010 The MHRA and CHM have published the January edition of Drug Safety Update (DSU). Highlights include: […]
NPC Archive Item: Government takes action on reducing the use of antipsychotic drugs in dementia
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 30 November 2009 The Government has accepted the findings and recommendations of an independent report on prescribing of antipsychotics in people with dementia. The report identifies an unacceptable level […]
NPC Archive Item: NICE updates depression guideline
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 5 November 2009 NICE has issued a clinical guideline on the treatment and management of depression in adults. The guideline makes recommendations on the identification, treatment and management of […]
NPC Archive Item: Antipsychotic use and life expectancy of people with schizophrenia
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 30th July 2009 An observational study in Finland confirms the large gap in life expectancy between people with schizophrenia and the general population. However, it also suggests that long-term […]
NPC Archive Item: Getting the Medicines Right: Medicines Management in Adult and Older Adult Acute Mental Health Wards.
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 28th July 2009 Introduction In July 2009 the document ‘Getting the Medicines Right: Medicines Management in Adult and Older Adult Acute Mental Health Wards’ was published to support the […]
NPC Archive Item: June Drug Safety Update from MHRA/CHM
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider 11th June 2009 The MHRA and CHM have published the June edition of Drug Safety Update. This issue gives […]
NPC Archive Item: Cholinesterase inhibitors associated with syncope in patients with dementia
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 18th May 2009 An observational study has found that cholinesterase inhibitors (donepezil, galantamine and rivastigmine▼) are associated with increased rates of syncope, bradycardia, permanent pacemaker insertion and hip fracture […]
NPC Archive Item: NICE updates schizophrenia guideline
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 2nd April 2009 NICE has updated its clinical guideline on the management of schizophrenia. With regard to choice of antipsychotic, NICE does not recommend use of any particular drug […]
NPC Archive Item: Evidence to support sertraline as first-line drug treatment option for major depression
NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 25th February 2009 A meta-analysis which considered the comparative efficacy of 12 second-generation antidepressants, has concluded that sertraline may be the best choice when starting treatment for moderate to […]